MIR4437

Across TCGA pan-cancer cohorts, MIR4437 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR4437 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR4437 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4437 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

STAD, BLCA, and HNSC are the cancer types where MIR4437 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.083	0.379	.001	54	view →
BLCA	OS	Tertile	All	0.225	0.686	.047	18	view →
HNSC	DFS	Tertile	II,III,IV	0.209	0.695	.043	9	view →
LAML	DFS	Tertile	All	0.551	0.326	.035	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR4437–STAD (DFS)

Open the STAD breakdown →